Unravelling the Utility of Modern Sulfonylureas From CVOTs and Landmark Trials: Expert Opinion from an International Panel

ConclusionModern SUs can be considered a cardiosafe option for the management of patients with diabetes mellitus and cardiovascular disease; thus CVOTs among individuals with T2DM are not required.
Source: Indian Heart Journal - Category: Cardiology Source Type: research